SELLAS Life Sciences Group, Inc (SLS) Stock Price

1.755 ▲ +0.135 (+8.33%)
Open: 1.66 Vol: 0 Day's range: 1.625 - 1.755 May 02, 12:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
SLS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 1.77▲ 1.69▲ 1.66▲ 1.56▲ 1.34▲
MA10 1.72▲ 1.65▲ 1.63▲ 1.44▲ 1.25▲
MA20 1.68▲ 1.62▲ 1.56▲ 1.30▲ 1.20▲
MA50 1.64▲ 1.53▲ 1.45▲ 1.22▲ 1.22▲
MA100 1.61▲ 1.45▲ 1.35▲ 1.17▲ 1.23▲
MA200 1.54▲ 1.34▲ 1.24▲ 1.20▲ 2.85▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.017▲ 0.014▲ 0.016▲ 0.053▲ 0.051▲
RSI 90.528▲ 81.264▲ 80.381▲ 87.571▲ 67.854▲
STOCH 100.000▲ 81.746▲ 77.831     83.886▲ 54.538    
WILL %R 0.000▲ 0.000▲ 0.000▲ 0.000▲ -1.708▲
CCI 141.341▲ 269.910▲ 221.169▲ 205.486▲ 199.125▲
Latest Filters Detected On SLS
▲ RSI&STOCH $SLS Overbought RSI + Stochastic Set Alert
▲ GAP $SLS Open Gap Up %2 Set Alert
▲ BREAK $SLS Price Breaks 60 Days High Set Alert
▲ BREAK $SLS Price Breaks 30 Days High Set Alert
▲ BREAK $SLS Price Breaks 20 Days High Set Alert
▲ BREAK $SLS Price Breaks 10 Days High Set Alert
SELLAS Life Sciences Group, Inc News
SELLAS Life Sciences Group, Inc. Common Stock (SLS)
Tuesday, April 29, 2025 02:34 PM
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
SELLAS Life Sciences Group, Inc. Presents Promising Preclinical Data on SLS009 for TP53 Mutated Acute Myeloid Leukemia at AACR 2025
Monday, April 28, 2025 05:50 AM
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the ...
SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference
Monday, April 28, 2025 05:45 AM
May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ...
SLS historical stock data
date open high low close volume
02/05/25 1.66 1.815 1.625 1.815 1,993,857
01/05/25 1.604 1.665 1.56 1.62 2,474,115
30/04/25 1.44 1.55 1.3818 1.55 1,783,603
29/04/25 1.44 1.56 1.415 1.425 3,356,878
28/04/25 1.43 1.45 1.35 1.41 2,751,971
25/04/25 1.36 1.47 1.36 1.40 2,442,204
24/04/25 1.32 1.35 1.29 1.34 1,358,588
23/04/25 1.31 1.38 1.30 1.31 1,687,165
22/04/25 1.29 1.32 1.265 1.29 967,015
21/04/25 1.32 1.40 1.27 1.29 1,810,431
Quote Details
52wk Low:0.772
52wk High:1.83
Vol:0
Avg Vol(3m):18.3M
1Y Chng:+24.32%
1M Chng:+51.25%
Add to Watch List
More Information
Index US Composite
Market Cap. 146.55M